<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03072979</url>
  </required_header>
  <id_info>
    <org_study_id>2016/01179</org_study_id>
    <nct_id>NCT03072979</nct_id>
  </id_info>
  <brief_title>A Study to Quantify Tumour Perfusion for Spine Metastasis Treated With Stereotactic Body Radiotherapy (SBRT)</brief_title>
  <official_title>Reduction in Tumour Perfusion for Spine Metastasis Treated With Stereotactic Body Radiotherapy (SBRT)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National University Hospital, Singapore</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National University, Singapore</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>National University Hospital, Singapore</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pre-clinical evidence suggests that radiotherapy reduces tumour-associated vasculature. The
      investigators will conduct a single-arm prospective study to quantify the reduction in tumour
      vasculature post-radiotherapy
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 21, 2017</start_date>
  <completion_date>December 31, 2018</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction in vasculature</measure>
    <time_frame>3 month</time_frame>
    <description>Reduction in vasculature measured by changes on Dynamic Contrast enhanced MRI</description>
  </primary_outcome>
  <enrollment type="Anticipated">18</enrollment>
  <condition>Spine Metastasis</condition>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Stereotactic body radiotherapy</intervention_name>
    <description>Stereotactic body radiotherapy</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        A total of 18 patients from National University Hospital (NUH) will be enrolled. Informed
        consent will be taken from patients prior to trial entry at NUH.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age â‰¥21 years of age

          -  Proven metastatic disease, excluding haematological and germ cell neoplasms

          -  Life expectancy &gt;3 months, Eastern Cooperative Oncology group (ECOG) 0-2

        Exclusion Criteria:

          -  The patient must not have an allergy to gadolinium contrast that will limit the
             ability to image the tumour by MRI safely even with the use of premedication

          -  eGFR &lt; 30 mL/min or if patient is suffering from acute renal insufficiency

          -  Prior radiotherapy to the specified region

          -  Recent surgery to affected spinal levels, or patients requiring immediate surgical
             intervention

          -  Spinal instability score (SINS) &gt;12

          -  Symptomatic cord compression (Bilksy grade 2 or 3), or worsening neurological deficits

          -  Body weight of more than 120kg

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>BALAMURUGAN VELLAYAPPAN, MBBS, FRANZCR</last_name>
    <phone>67795555</phone>
    <email>bala_vellayappan@nuhs.edu.sg</email>
  </overall_contact>
  <location>
    <facility>
      <name>National University Hospital</name>
      <address>
        <city>Singapore</city>
        <country>Singapore</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>BALAMURUGAN VELLAYAPPAN</last_name>
      <email>bala_vellayappan@nuhs.edu.sg</email>
    </contact>
  </location>
  <location_countries>
    <country>Singapore</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 28, 2017</study_first_submitted>
  <study_first_submitted_qc>March 2, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 8, 2017</study_first_posted>
  <last_update_submitted>March 2, 2017</last_update_submitted>
  <last_update_submitted_qc>March 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 8, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National University Hospital, Singapore</investigator_affiliation>
    <investigator_full_name>Radiation Oncology</investigator_full_name>
    <investigator_title>Dr Balamurugan Vellayappan</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasm Metastasis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

